Literature DB >> 7636099

Polycythemia as a complication of testosterone replacement therapy in nursing home men with low testosterone levels.

P J Drinka1, A L Jochen, M Cuisinier, R Bloom, I Rudman, D Rudman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7636099     DOI： 10.1111/j.1532-5415.1995.tb05534.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN： 0002-8614            Impact factor:   5.562


× No keyword cloud information.
  15 in total

Review 1.  Risks versus benefits of testosterone therapy in elderly men.

Authors:  S Basaria; A S Dobs
Journal:  Drugs Aging       Date:  1999-08       Impact factor: 3.923

Review 2.  Age-related changes in male gonadal function. Implications for therapy.

Authors:  D Maas; A Jochen; B Lalande
Journal:  Drugs Aging       Date:  1997-07       Impact factor: 3.923

3.  Androgen replacement therapy in the aging male.

Authors:  Jeremy B Myers; Randall B Meacham
Journal:  Rev Urol       Date:  2003

Review 4.  Testosterone therapy and secondary erythrocytosis.

Authors:  Joshua White; Francis Petrella; Jesse Ory
Journal:  Int J Impot Res       Date:  2022-01-06       Impact factor: 2.896

Review 5.  Androgens and erythropoiesis: past and present.

Authors:  S Shahani; M Braga-Basaria; M Maggio; S Basaria
Journal:  J Endocrinol Invest       Date:  2009-04-07       Impact factor: 4.256

6.  Beta 2-agonist administration reverses muscle wasting and improves muscle function in aged rats.

Authors:  James G Ryall; David R Plant; Paul Gregorevic; Martin N Sillence; Gordon S Lynch
Journal:  J Physiol       Date:  2003-11-14       Impact factor: 5.182

7.  The risk of adverse outcomes in association with use of testosterone products: a cohort study using the UK-based general practice research database.

Authors:  Susan S Jick; Katrina Wilcox Hagberg
Journal:  Br J Clin Pharmacol       Date:  2013-01       Impact factor: 4.335

Review 8.  Androgen deficiency in the aging male: when to evaluate and when to treat.

Authors:  W E Nolten
Journal:  Curr Urol Rep       Date:  2000-12       Impact factor: 2.862

9.  The benefits and risks of testosterone replacement therapy: a review.

Authors:  Nazem Bassil; Saad Alkaade; John E Morley
Journal:  Ther Clin Risk Manag       Date:  2009-06-22       Impact factor: 2.423

10.  Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations.

Authors:  C Wang; E Nieschlag; R Swerdloff; H M Behre; W J Hellstrom; L J Gooren; J M Kaufman; J-J Legros; B Lunenfeld; A Morales; J E Morley; C Schulman; I M Thompson; W Weidner; F C W Wu
Journal:  Eur J Endocrinol       Date:  2008-11       Impact factor: 6.664
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.